Valvular heart disease in pregnancy

被引:10
|
作者
Scirica B.M. [1 ]
O'Gara P.T. [1 ]
机构
[1] Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02461
关键词
Warfarin; Aortic Stenosis; Mitral Regurgitation; Aortic Regurgitation; Valvular Heart Disease;
D O I
10.1007/s11886-006-0017-y
中图分类号
学科分类号
摘要
Women with valvular disease who are pregnant or planning to conceive require careful evaluation and management. Pregnancy is associated with normal physiologic changes that can aggravate many valvular conditions and may require the initiation or increase of cardiovascular medications to manage fluid overload or arrhythmias. Most women will tolerate pregnancy and delivery without major complication, though some types of valvular heart disease are poorly tolerated and require more intensive management, or even termination of the pregnancy. In addition, patients at risk of thromboembolism and those who have prosthetic cardiac valves require anticoagulation. The decision regarding the choice and intensity of anticoagulation requires careful balance between the individual risks of thrombosis and bleeding in the mother and harm to the fetus. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:83 / 89
页数:6
相关论文
共 50 条
  • [31] Maternal and fetal outcomes of pregnancy with valvular heart disease
    Virginia, N.
    Pramono, M. B. A.
    Herry, Y.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0B) : B38 - B38
  • [32] Congenital heart disease and acquired valvular lesions in pregnancy
    Horstkotte, D
    Fassbender, D
    Piper, C
    HERZ, 2003, 28 (03) : 227 - 239
  • [33] Pregnancy in women with valvular heart disease: maternal and perinatal outcomes
    Curry, R.
    Gelson, E.
    Gatzoulis, M.
    Swan, L.
    Steer, P.
    Johnson, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 22 - 23
  • [34] The effect of valvular heart disease on maternal and fetal outcome of pregnancy
    Hameed, A
    Karaalp, IS
    Tummala, PP
    Wani, OR
    Canetti, M
    Akhter, MW
    Goodwin, M
    Zapadinsky, N
    Elkayam, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) : 893 - 899
  • [35] Valvular heart disease and pregnancy - Part I: Native valves
    Elkayam, U
    Bitar, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (02) : 223 - 230
  • [36] Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment
    Gupta, Rahul
    Malik, Aaqib H.
    Ranchal, Purva
    Aronow, Wilbert S.
    Vyas, Apurva V.
    Rajeswaran, Yasotha
    Quinones, Joanne
    Ahnert, Amy M.
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (03)
  • [37] A case series of anticoagulation in mechanical and valvular heart disease in pregnancy
    White, K.
    Bowles, L.
    Shawne-Taylor, M.
    Von Klemperer, K.
    Deaner, A.
    Khan, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 161 - 161
  • [38] Valvular heart disease and pregnancy - Part II: Prosthetic valves
    Elkayam, U
    Bitar, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) : 403 - 410
  • [39] Valvular heart disease in pregnancy: Effects on maternal and fetal outcome
    Hameed, AB
    Wani, OR
    Karaalp, IS
    Tummala, PP
    Canetti, M
    Goodwin, M
    Elkayam, U
    CIRCULATION, 1999, 100 (18) : 148 - 149
  • [40] Obstetrics Course of Pregnancy in Women with maternal Valvular Heart Disease
    Lorenz, Judith
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2020, 224 (06): : 327 - +